{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:43:59Z","timestamp":1778885039205,"version":"3.51.4"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-110944RB-I00"],"award-info":[{"award-number":["PID2019-110944RB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-139865OB-I00"],"award-info":[{"award-number":["PID2022-139865OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["CEX2018-000789-S-20-1"],"award-info":[{"award-number":["CEX2018-000789-S-20-1"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-119692RB-C22"],"award-info":[{"award-number":["PID2020-119692RB-C22"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-107557RB-I00"],"award-info":[{"award-number":["PID2019-107557RB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-142386OB-I00"],"award-info":[{"award-number":["PID2022-142386OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["964808"],"award-info":[{"award-number":["964808"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC24\/00111"],"award-info":[{"award-number":["AC24\/00111"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00890"],"award-info":[{"award-number":["PI16\/00890"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00789"],"award-info":[{"award-number":["PI21\/00789"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["TRNSC247900ALCA"],"award-info":[{"award-number":["TRNSC247900ALCA"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR 661"],"award-info":[{"award-number":["SGR 661"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR 523"],"award-info":[{"award-number":["SGR 523"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR552"],"award-info":[{"award-number":["SGR552"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["SGR01289"],"award-info":[{"award-number":["SGR01289"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008050","name":"Fundaci\u00f3n Cellex","doi-asserted-by":"publisher","award":["n.a."],"award-info":[{"award-number":["n.a."]}],"id":[{"id":"10.13039\/100008050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005774","name":"Universitat de Barcelona","doi-asserted-by":"publisher","award":["APIF predoctoral fellowship"],"award-info":[{"award-number":["APIF predoctoral fellowship"]}],"id":[{"id":"10.13039\/501100005774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ci\u00eancia sem Fronteiras CNPq"},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["FPU22\/00065"],"award-info":[{"award-number":["FPU22\/00065"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2022\/CDF1167"],"award-info":[{"award-number":["2022\/CDF1167"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["301\/C\/2019"],"award-info":[{"award-number":["301\/C\/2019"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL157424"],"award-info":[{"award-number":["R01 HL157424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-small cell lung cancer (NSCLC) exhibits disparate responses to anti-angiogenic therapies between its two major histologic subtypes, lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC), suggesting a histotype-dependent angiogenesis regulation. Tumor-associated fibroblasts (TAFs) exhibit an activated\/myofibroblast-like phenotype in NSCLC, and are emerging as major regulators of tumor progression; yet, their role in controlling angiogenesis in NSCLC remains undefined. Here we analyzed angiogenesis\/hypoxia markers in NSCLC, and combined transcriptomics (bulk RNA-seq, scRNA-seq), angiogenesis arrays, genetic perturbations and functional in vitro and in vivo assays to dissect the histotype-dependent production of pro-angiogenic factors in TAFs. We observed greater angiogenesis and reduced necrosis\/hypoxia in LUAD compared to LUSC across multiple patient cohorts. The LUAD-TAF secretome was primed for angiogenesis through SMAD3-dependent overproduction of key regulators, particularly TIMP-1 and VEGF-A. We also uncovered a novel function for TIMP-1 in promoting endothelial cell hyperbranching over basal VEGF signaling. Conversely, LUSC-TAFs displayed diminished angiogenic effects despite upregulating HIF-1\u03b1 and a hypoxia-associated transcriptional signature, owing to their lower SMAD3 and compensatory increase in SMAD2. Our study unveils the critical influence of TAFs in shaping the distinct angiogenic landscapes in LUAD and LUSC through the opposing SMAD2\/3 regulation of TIMP-1, VEGF-A and hypoxia signaling. These results also highlight the therapeutic potential of targeting stromal SMAD3\/TIMP-1 in LUAD or microenvironmental stressors such as hypoxia and acidosis in LUSC. In addition, these findings provide a biological framework for understanding the histotype-dependent patterns of dissemination, immune evasion, and response to anti-angiogenic therapies in NSCLC.<\/jats:p>","DOI":"10.1038\/s41419-026-08677-2","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:25:04Z","timestamp":1774873504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antagonistic SMAD2\/3 control of TIMP-1, VEGF-A, and hypoxia signaling in myofibroblasts shapes histotype-specific angiogenesis in lung cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8063-2598","authenticated-orcid":false,"given":"Natalia","family":"D\u00edaz-Valdivia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Duch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Ikemori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marselina","family":"Arshakyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-3254","authenticated-orcid":false,"given":"Alejandro","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rodr\u00edguez-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Lluis","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-5086","authenticated-orcid":false,"given":"Erik","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fillat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-1648","authenticated-orcid":false,"given":"Manel","family":"Juan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9674-5554","authenticated-orcid":false,"given":"Ernest","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noem\u00ed","family":"Reguart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek C.","family":"Radisky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Casanovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7898-1599","authenticated-orcid":false,"given":"Jordi","family":"Alcaraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"8677_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"8677_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446\u201354. https:\/\/doi.org\/10.1038\/nature25183.","journal-title":"Nature"},{"key":"8677_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15:325\u201340. https:\/\/doi.org\/10.1038\/nrclinonc.2018.29.","journal-title":"Nat Rev Clin Oncol"},{"key":"8677_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17:457\u201374. https:\/\/doi.org\/10.1038\/nrc.2017.51.","journal-title":"Nat Rev Cancer"},{"key":"8677_CR5","doi-asserted-by":"publisher","first-page":"610903","DOI":"10.3389\/fcell.2020.610903","volume":"8","author":"S Daum","year":"2020","unstructured":"Daum S, Hagen H, Naismith E, Wolf D, Pircher A. The role of anti-angiogenesis in the treatment landscape of non-small cell lung cancer - new combinational approaches and strategies of neovessel inhibition. Front Cell Dev Biol. 2020;8:610903 https:\/\/doi.org\/10.3389\/fcell.2020.610903.","journal-title":"Front Cell Dev Biol"},{"key":"8677_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","volume":"11","author":"L Bejarano","year":"2021","unstructured":"Bejarano L, Jord\u00e3o MJC, Joyce JA. Therapeutic targeting of the tumor microenvironment. Cancer Discov. 2021;11:933\u201359. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1808.","journal-title":"Cancer Discov"},{"key":"8677_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.689132","volume":"12","author":"S Ren","year":"2021","unstructured":"Ren S, Xiong X, You H, Shen J, Zhou P. The combination of immune checkpoint blockade and angiogenesis inhibitors in the treatment of advanced non-small cell lung cancer. Front Immunol. 2021;12:689132. https:\/\/doi.org\/10.3389\/fimmu.2021.689132.","journal-title":"Front Immunol"},{"key":"8677_CR8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41416-020-01201-z","volume":"124","author":"R Kato","year":"2021","unstructured":"Kato R, Haratani K, Hayashi H, Sakai K, Sakai H, Kawakami H, et al. Nintedanib promotes antitumour immunity and shows antitumour activity in combination with PD-1 blockade in mice: potential role of cancer-associated fibroblasts. Br J Cancer. 2021;124:914\u201324. https:\/\/doi.org\/10.1038\/s41416-020-01201-z.","journal-title":"Br J Cancer"},{"key":"8677_CR9","doi-asserted-by":"publisher","unstructured":"Kim HR, Sugawara S, Lee JS, Kang JH, Inui N, Hida T, et al. First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: updated survival analysis of the ONO-4538-52\/TASUKI-52 randomized controlled trial. Cancer Med. 2023. https:\/\/doi.org\/10.1002\/cam4.6348","DOI":"10.1002\/cam4.6348"},{"key":"8677_CR10","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1200\/jco.22.00912","volume":"40","author":"KL Reckamp","year":"2022","unstructured":"Reckamp KL, Redman MW, Dragnev KH, Minichiello K, Villaruz LC, Faller B, et al. Phase II randomized study of ramucirumab and pembrolizumab versus standard of care in advanced non-small-cell lung cancer previously treated with immunotherapy-Lung-MAP S1800A. J Clin Oncol. 2022;40:2295\u2013306. https:\/\/doi.org\/10.1200\/jco.22.00912.","journal-title":"J Clin Oncol"},{"key":"8677_CR11","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1200\/JCO.23.01891","volume":"42","author":"S Park","year":"2024","unstructured":"Park S, Kim TM, Han JY, Lee GW, Shim BY, Lee YG, et al. Phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR- or ALK-mutated non-small-cell lung cancer (ATTLAS, KCSG-LU19-04). J Clin Oncol. 2024;42:1241\u201351. https:\/\/doi.org\/10.1200\/JCO.23.01891.","journal-title":"J Clin Oncol"},{"key":"8677_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s1470-2045(13)70586-2","volume":"15","author":"M Reck","year":"2014","unstructured":"Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial. Lancet Oncol. 2014;15:143\u201355. https:\/\/doi.org\/10.1016\/s1470-2045(13)70586-2.","journal-title":"Lancet Oncol"},{"key":"8677_CR13","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1056\/NEJMoa1716948","volume":"378","author":"MA Socinski","year":"2018","unstructured":"Socinski MA, Jotte RM, Cappuzzo F, Orlandi F, Stroyakovskiy D, Nogami N, et al. Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC. N Engl J Med. 2018;378:2288\u2013301. https:\/\/doi.org\/10.1056\/NEJMoa1716948.","journal-title":"N Engl J Med"},{"key":"8677_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/emmm.201303214","volume":"6","author":"M Larrayoz","year":"2014","unstructured":"Larrayoz M, Pio R, Pajares MJ, Zudaire I, Ajona D, Casanovas O, et al. Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. EMBO Mol Med. 2014;6:539\u201350. https:\/\/doi.org\/10.1002\/emmm.201303214.","journal-title":"EMBO Mol Med"},{"key":"8677_CR15","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1200\/jco.2004.11.022","volume":"22","author":"DH Johnson","year":"2004","unstructured":"Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 2004;22:2184\u201391. https:\/\/doi.org\/10.1200\/jco.2004.11.022.","journal-title":"J Clin Oncol"},{"key":"8677_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10:417\u201327. https:\/\/doi.org\/10.1038\/nrd3455.","journal-title":"Nat Rev Drug Discov"},{"key":"8677_CR17","doi-asserted-by":"publisher","unstructured":"Foster DS, Jones RE, Ransom RC, Longaker MT, Norton JA. The evolving relationship of wound healing and tumor stroma. JCI Insight. 2018 ;3. https:\/\/doi.org\/10.1172\/jci.insight.99911.","DOI":"10.1172\/jci.insight.99911"},{"key":"8677_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"key":"8677_CR19","doi-asserted-by":"publisher","first-page":"111827","DOI":"10.1016\/j.cellsig.2025.111827","volume":"132","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang Q, Wang Y. CAF-mediated tumor vascularization: from mechanistic insights to targeted therapies. Cell Signal. 2025;132:111827 https:\/\/doi.org\/10.1016\/j.cellsig.2025.111827.","journal-title":"Cell Signal"},{"key":"8677_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2019.07.020","volume":"135","author":"J Alcaraz","year":"2019","unstructured":"Alcaraz J, Carrasco JL, Millares L, Luis IC, Fern\u00e1ndez-Porras FJ, Mart\u00ednez-Romero A, et al. Stromal markers of activated tumor-associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer. Lung Cancer. 2019;135:151\u201360. https:\/\/doi.org\/10.1016\/j.lungcan.2019.07.020.","journal-title":"Lung Cancer"},{"key":"8677_CR21","doi-asserted-by":"publisher","unstructured":"Cords L, Engler S, Haberecker M, R\u00fcschoff JH, Moch H, de Souza N, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.021.","DOI":"10.1016\/j.ccell.2023.12.021"},{"key":"8677_CR22","first-page":"1453","volume":"36","author":"M Vizoso","year":"2015","unstructured":"Vizoso M, Puig M, Carmona FJ, Maqueda M, Vel\u00e1squez A, G\u00f3mez A, et al. Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts. Carcinogenesis. 2015;36:1453\u201363.","journal-title":"Carcinogenesis"},{"key":"8677_CR23","doi-asserted-by":"publisher","unstructured":"Alcaraz J, Ikemori R, Llorente A, D\u00edaz-Valdivia N, Reguart N, Vizoso M. Epigenetic reprogramming of tumor-associated fibroblasts in lung cancer: therapeutic opportunities. Cancers. 2021;13. https:\/\/doi.org\/10.3390\/cancers13153782.","DOI":"10.3390\/cancers13153782"},{"key":"8677_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/0008-5472.can-19-0637","volume":"80","author":"R Ikemori","year":"2020","unstructured":"Ikemori R, Gabasa M, Duch P, Vizoso M, Bragado P, Arshakyan M, et al. Epigenetic SMAD3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma. Cancer Res. 2020;80:276\u201390. https:\/\/doi.org\/10.1158\/0008-5472.can-19-0637.","journal-title":"Cancer Res"},{"key":"8677_CR25","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","volume":"42","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li J, Cheng W, Diao T, Liu H, Bo Y, et al. Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation. Cancer Cell. 2024;42:1764\u20131783.e10. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.020.","journal-title":"Cancer Cell"},{"key":"8677_CR26","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors. Cancer Discov. 2022;12:2606\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1714.","journal-title":"Cancer Discov"},{"key":"8677_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.70102","author":"A Bernardo","year":"2025","unstructured":"Bernardo A, D\u00edaz-Valdivia N, Fern\u00e1ndez-Nogueira P, Alcaraz J. Stromagenesis and cancer-associated fibroblast heterogeneity in primary tumors and metastasis: focus on non-small cell lung cancer. FEBS Open Biol. 2025. https:\/\/doi.org\/10.1002\/2211-5463.70102.","journal-title":"FEBS Open Biol"},{"key":"8677_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-72","volume":"14","author":"JP Paschoal","year":"2014","unstructured":"Paschoal JP, Bernardo V, Canedo NH, Ribeiro OD, Caroli-Bottino A, Pannain VL. Microvascular density of regenerative nodules to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression. BMC Cancer. 2014;14:72. https:\/\/doi.org\/10.1186\/1471-2407-14-72.","journal-title":"BMC Cancer"},{"key":"8677_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24:1277\u201389. https:\/\/doi.org\/10.1038\/s41591-018-0096-5.","journal-title":"Nat Med"},{"key":"8677_CR30","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317\u20131334.e10. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.009.","journal-title":"Immunity"},{"key":"8677_CR31","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/j.clon.2021.08.014","volume":"33","author":"MR Horsman","year":"2021","unstructured":"Horsman MR, S\u00f8rensen BS, Busk M, Siemann DW. Therapeutic modification of hypoxia. Clin Oncol. 2021;33:e492\u2013509. https:\/\/doi.org\/10.1016\/j.clon.2021.08.014.","journal-title":"Clin Oncol"},{"key":"8677_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. 2025;20:180\u2013219. https:\/\/doi.org\/10.1038\/s41596-024-01045-4.","journal-title":"Nat Protoc"},{"key":"8677_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67289-8","volume":"10","author":"G Carpentier","year":"2020","unstructured":"Carpentier G, Berndt S, Ferratge S, Rasband W, Cuendet M, Uzan G, et al. Angiogenesis analyzer for ImageJ\u2014a comparative morphometric analysis of \u201cEndothelial Tube Formation Assay\u201d and \u201cFibrin Bead Assay\u201d. Sci Rep. 2020;10:11568. https:\/\/doi.org\/10.1038\/s41598-020-67289-8.","journal-title":"Sci Rep"},{"key":"8677_CR34","doi-asserted-by":"publisher","first-page":"82324","DOI":"10.18632\/oncotarget.10327","volume":"7","author":"R Lugo","year":"2016","unstructured":"Lugo R, Gabasa M, Andriani F, Puig F, Facchinetti F, Ram\u00edrez J, et al. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung. Oncotarget. 2016;7:82324\u201337.","journal-title":"Oncotarget"},{"key":"8677_CR35","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O","volume":"91","author":"Y Hasegawa","year":"2001","unstructured":"Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K. Transforming growth factor-beta 1 level correlates with angiogenesis, tumor progression, and prognosis in patients with non-small cell lung carcinoma. Cancer. 2001;91:964\u201371.","journal-title":"Cancer"},{"key":"8677_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00005-006-0016-0","volume":"54","author":"J Domaga\u0142a-Kulawik","year":"2006","unstructured":"Domaga\u0142a-Kulawik J, Hoser G, Safianowska A, Grubek-Jaworska H, Chazan R. Elevated TGF-beta1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp. 2006;54:143\u20137. https:\/\/doi.org\/10.1007\/s00005-006-0016-0.","journal-title":"Arch Immunol Ther Exp"},{"key":"8677_CR37","doi-asserted-by":"publisher","first-page":"e1008055","DOI":"10.1371\/journal.pcbi.1008055","volume":"17","author":"D Stepanova","year":"2021","unstructured":"Stepanova D, Byrne HM, Maini PK, Alarc\u00f3n T. A multiscale model of complex endothelial cell dynamics in early angiogenesis. PLoS Comput Biol. 2021;17:e1008055 https:\/\/doi.org\/10.1371\/journal.pcbi.1008055.","journal-title":"PLoS Comput Biol"},{"key":"8677_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbrc.2004.12.032","volume":"327","author":"T Kobayashi","year":"2005","unstructured":"Kobayashi T, Liu X, Wen FQ, Fang Q, Abe S, Wang XQ, et al. Smad3 mediates TGF-beta1 induction of VEGF production in lung fibroblasts. Biochem Biophys Res Commun. 2005;327:393\u20138. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.032.","journal-title":"Biochem Biophys Res Commun"},{"key":"8677_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/s41416-022-02093-x","volume":"128","author":"Y Juste-Lanas","year":"2023","unstructured":"Juste-Lanas Y, D\u00edaz-Valdivia N, Llorente A, Ikemori R, Bernardo A, Arshakyan M, et al. 3D collagen migration patterns reveal a SMAD3-dependent and TGF-\u03b21-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma. Br J Cancer. 2023;128:967\u201381. https:\/\/doi.org\/10.1038\/s41416-022-02093-x.","journal-title":"Br J Cancer"},{"key":"8677_CR40","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/cas.16141","volume":"115","author":"P Duch","year":"2024","unstructured":"Duch P, D\u00edaz-Valdivia N, Gabasa M, Ikemori R, Arshakyan M, Fern\u00e1ndez-Nogueira P, et al. Aberrant TIMP-1 production in tumor-associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma. Cancer Sci. 2024;115:1505\u201319. https:\/\/doi.org\/10.1111\/cas.16141.","journal-title":"Cancer Sci"},{"key":"8677_CR41","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ijc.11094","volume":"105","author":"Y Ikenaka","year":"2003","unstructured":"Ikenaka Y, Yoshiji H, Kuriyama S, Yoshii J, Noguchi R, Tsujinoue H, et al. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer. 2003;105:340\u20136. https:\/\/doi.org\/10.1002\/ijc.11094.","journal-title":"Int J Cancer"},{"key":"8677_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10456-008-9102-8","volume":"11","author":"H Liu","year":"2008","unstructured":"Liu H, Chen B, Lilly B. Fibroblasts potentiate blood vessel formation partially through secreted factor TIMP-1. Angiogenesis. 2008;11:223\u201334. https:\/\/doi.org\/10.1007\/s10456-008-9102-8.","journal-title":"Angiogenesis"},{"key":"8677_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.matbio.2022.06.009","volume":"111","author":"P Duch","year":"2022","unstructured":"Duch P, D\u00edaz-Valdivia N, Ikemori R, Gabasa M, Radisky ES, Arshakyan M, et al. Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biol. 2022;111:207\u201325. https:\/\/doi.org\/10.1016\/j.matbio.2022.06.009.","journal-title":"Matrix Biol"},{"key":"8677_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14:4294. https:\/\/doi.org\/10.1038\/s41467-023-39762-1.","journal-title":"Nat Commun"},{"key":"8677_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14:535\u201346. https:\/\/doi.org\/10.1038\/nrc3775.","journal-title":"Nat Rev Cancer"},{"key":"8677_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76556-7","volume":"10","author":"I Elisia","year":"2020","unstructured":"Elisia I, Lam V, Cho B, Hay M, Li MY, Yeung M, et al. The effect of smoking on chronic inflammation, immune function and blood cell composition. Sci Rep. 2020;10:19480. https:\/\/doi.org\/10.1038\/s41598-020-76556-7.","journal-title":"Sci Rep"},{"key":"8677_CR47","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1111\/jcmm.16556","volume":"25","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Bian Y, Wang Y, Wang Y, Duan X, Han Y, et al. HIF-1\u03b1 is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer. J Cell Mol Med. 2021;25:5457\u201369. https:\/\/doi.org\/10.1111\/jcmm.16556.","journal-title":"J Cell Mol Med"},{"key":"8677_CR48","doi-asserted-by":"publisher","first-page":"7707","DOI":"10.1002\/jcb.27120","volume":"119","author":"H Zhu","year":"2018","unstructured":"Zhu H, Zhang S. Hypoxia inducible factor-1\u03b1\/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. J Cell Biochem. 2018;119:7707\u201318. https:\/\/doi.org\/10.1002\/jcb.27120.","journal-title":"J Cell Biochem"},{"key":"8677_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.aaw7875","volume":"365","author":"LL Munn","year":"2019","unstructured":"Munn LL, Jain RK. Vascular regulation of antitumor immunity. Science. 2019;365:544\u20135. https:\/\/doi.org\/10.1126\/science.aaw7875.","journal-title":"Science"},{"key":"8677_CR50","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1272\/jnms.74.344","volume":"74","author":"C Morishita","year":"2007","unstructured":"Morishita C, Jin E, Kikuchi M, Egawa S, Fujiwara M, Ohaki Y, et al. Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma. J Nippon Med Sch. 2007;74:344\u201354. https:\/\/doi.org\/10.1272\/jnms.74.344.","journal-title":"J Nippon Med Sch"},{"key":"8677_CR51","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.humpath.2013.01.004","volume":"44","author":"S Yazdani","year":"2013","unstructured":"Yazdani S, Miki Y, Tamaki K, Ono K, Iwabuchi E, Abe K, et al. Proliferation and maturation of intratumoral blood vessels in non-small cell lung cancer. Hum Pathol. 2013;44:1586\u201396. https:\/\/doi.org\/10.1016\/j.humpath.2013.01.004.","journal-title":"Hum Pathol"},{"key":"8677_CR52","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1164\/ajrccm.152.6.8520790","volume":"152","author":"A Yuan","year":"1995","unstructured":"Yuan A, Yang PC, Yu CJ, Lee YC, Yao YT, Chen CL, et al. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med. 1995;152:2157\u201362. https:\/\/doi.org\/10.1164\/ajrccm.152.6.8520790.","journal-title":"Am J Respir Crit Care Med"},{"key":"8677_CR53","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1523-1755.2004.00780.x","volume":"66","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Li JH, Garcia G, Mu W, Piek E, B\u00f6ttinger EP, et al. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int. 2004;66:605\u201313. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00780.x.","journal-title":"Kidney Int"},{"key":"8677_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.282","volume":"5","author":"X Shi","year":"2014","unstructured":"Shi X, Guo LW, Seedial SM, Si Y, Wang B, Takayama T, et al. TGF-\u03b2\/Smad3 inhibits vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. Cell Death Dis. 2014;5:e1317. https:\/\/doi.org\/10.1038\/cddis.2014.282.","journal-title":"Cell Death Dis"},{"key":"8677_CR55","doi-asserted-by":"publisher","first-page":"35337","DOI":"10.1074\/jbc.M803342200","volume":"283","author":"RL Clifford","year":"2008","unstructured":"Clifford RL, Deacon K, Knox AJ. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). J Biol Chem. 2008;283:35337\u201353. https:\/\/doi.org\/10.1074\/jbc.M803342200.","journal-title":"J Biol Chem"},{"key":"8677_CR56","doi-asserted-by":"publisher","first-page":"39403","DOI":"10.1074\/jbc.M504140200","volume":"280","author":"ES Akool","year":"2005","unstructured":"Akool ES, Doller A, M\u00fcller R, Gutwein P, Xin C, Huwiler A, et al. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor beta-Smad signaling pathway. J Biol Chem. 2005;280:39403\u201316. https:\/\/doi.org\/10.1074\/jbc.M504140200.","journal-title":"J Biol Chem"},{"key":"8677_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11010-014-2258-1","volume":"400","author":"L Zhang","year":"2015","unstructured":"Zhang L, Liu C, Meng Xming, Huang C, Xu F, Li J. Smad2 protects against TGF-beta 1\/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem. 2015;400:17\u201328. https:\/\/doi.org\/10.1007\/s11010-014-2258-1.","journal-title":"Mol Cell Biochem"},{"key":"8677_CR58","doi-asserted-by":"publisher","first-page":"118703","DOI":"10.1016\/j.bbamcr.2020.118703","volume":"1867","author":"S Huang","year":"2020","unstructured":"Huang S, Chen B, Humeres C, Alex L, Hanna A, Frangogiannis NG. The role of Smad2 and Smad3 in regulating homeostatic functions of fibroblasts in vitro and in adult mice. Biochim Biophys Acta Mol Cell Res. 2020;1867:118703 https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118703.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"8677_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0169-5002(01)00470-6","volume":"36","author":"M Yamaguchi","year":"2002","unstructured":"Yamaguchi M, Sugio K, Ondo K, Yano T, Sugimachi K. Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer Amst Neth. 2002;36:143\u201350. https:\/\/doi.org\/10.1016\/s0169-5002(01)00470-6.","journal-title":"Lung Cancer Amst Neth"},{"key":"8677_CR60","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/onc.2009.426","volume":"29","author":"M Petersen","year":"2010","unstructured":"Petersen M, Pardali E, van der Horst G, Cheung H, van den Hoogen C, van der Pluijm G, et al. Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene. 2010;29:1351\u201361. https:\/\/doi.org\/10.1038\/onc.2009.426.","journal-title":"Oncogene"},{"key":"8677_CR61","doi-asserted-by":"publisher","first-page":"a022210","DOI":"10.1101\/cshperspect.a022210","volume":"10","author":"MJ Goumans","year":"2018","unstructured":"Goumans MJ, Ten Dijke P. TGF-\u03b2 signaling in control of cardiovascular function. Cold Spring Harb Perspect Biol. 2018;10:a022210 https:\/\/doi.org\/10.1101\/cshperspect.a022210.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8677_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-00436-9","volume":"6","author":"S Liu","year":"2021","unstructured":"Liu S, Ren J, Ten Dijke P. Targeting TGF\u03b2 signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:8 https:\/\/doi.org\/10.1038\/s41392-020-00436-9.","journal-title":"Signal Transduct Target Ther"},{"key":"8677_CR63","doi-asserted-by":"publisher","first-page":"C866","DOI":"10.1152\/ajpcell.00227.2022","volume":"323","author":"CA Steiner","year":"2022","unstructured":"Steiner CA, Cartwright IM, Taylor CT, Colgan SP. Hypoxia-inducible factor as a bridge between healthy barrier function, wound healing, and fibrosis. Am J Physiol Cell Physiol. 2022;323:C866\u201378. https:\/\/doi.org\/10.1152\/ajpcell.00227.2022.","journal-title":"Am J Physiol Cell Physiol"},{"key":"8677_CR64","doi-asserted-by":"publisher","first-page":"38527","DOI":"10.1074\/jbc.M104536200","volume":"276","author":"T S\u00e1nchez-Elsner","year":"2001","unstructured":"S\u00e1nchez-Elsner T, Botella LM, Velasco B, Corb\u00ed A, Attisano L, Bernab\u00e9u C. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem. 2001;276:38527\u201335. https:\/\/doi.org\/10.1074\/jbc.M104536200.","journal-title":"J Biol Chem"},{"key":"8677_CR65","doi-asserted-by":"publisher","first-page":"19060","DOI":"10.1074\/jbc.M113.468199","volume":"288","author":"S Tugues","year":"2013","unstructured":"Tugues S, Honjo S, K\u00f6nig C, Padhan N, Kroon J, Gualandi L, et al. Tetraspanin CD63 promotes vascular endothelial growth factor receptor 2-\u03b21 integrin complex formation, thereby regulating activation and downstream signaling in endothelial cells in vitro and in vivo. J Biol Chem. 2013;288:19060\u201371. https:\/\/doi.org\/10.1074\/jbc.M113.468199.","journal-title":"J Biol Chem"},{"key":"8677_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14670\/HH-16.87","volume":"16","author":"E Yamada","year":"2001","unstructured":"Yamada E, Tobe T, Yamada H, Okamoto N, Zack DJ, Werb Z, et al. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol. 2001;16:87\u201397. https:\/\/doi.org\/10.14670\/HH-16.87.","journal-title":"Histol Histopathol"},{"key":"8677_CR67","first-page":"4031","volume":"31","author":"M Pesta","year":"2011","unstructured":"Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, et al. Prognostic significance of TIMP-1 in non-small cell lung cancer. Anticancer Res. 2011;31:4031\u20138.","journal-title":"Anticancer Res"},{"key":"8677_CR68","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.20425","volume":"40","author":"CJ Parsons","year":"2004","unstructured":"Parsons CJ, Bradford BU, Pan CQ, Cheung E, Schauer M, Knorr A, et al. Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats. Hepatology. 2004;40:1106\u201315. https:\/\/doi.org\/10.1002\/hep.20425.","journal-title":"Hepatology"},{"key":"8677_CR69","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1172\/JCI88696","volume":"127","author":"JH Kang","year":"2017","unstructured":"Kang JH, Jung MY, Yin X, Andrianifahanana M, Hernandez DM, Leof EB. Cell-penetrating peptides selectively targeting SMAD3 inhibit profibrotic TGF-\u03b2 signaling. J Clin Investig. 2017;127:2541\u201354. https:\/\/doi.org\/10.1172\/JCI88696.","journal-title":"J Clin Investig"},{"key":"8677_CR70","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3324\/haematol.2014.121590","volume":"100","author":"J Kobuch","year":"2015","unstructured":"Kobuch J, Cui H, Gr\u00fcnwald B, Saftig P, Knolle PA, Kr\u00fcger A. TIMP-1 signaling via CD63 triggers granulopoiesis and neutrophilia in mice. Haematologica. 2015;100:1005\u201313. https:\/\/doi.org\/10.3324\/haematol.2014.121590.","journal-title":"Haematologica"},{"key":"8677_CR71","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0140-6736(00)82038-3","volume":"355","author":"PC Hoffman","year":"2000","unstructured":"Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479\u201385. https:\/\/doi.org\/10.1016\/s0140-6736(00)82038-3.","journal-title":"Lancet"},{"key":"8677_CR72","doi-asserted-by":"publisher","first-page":"397","DOI":"10.21037\/atm-20-968","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang S, Qu X, Li Z, Che X, Cao L, Yang X, et al. Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients. Ann Transl Med. 2021;9:397 https:\/\/doi.org\/10.21037\/atm-20-968.","journal-title":"Ann Transl Med"},{"key":"8677_CR73","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher S, Sturm G, Horvath L, Untergasser G, Kuempers C, Fotakis G, et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell. 2022;40:1503\u20131520.e8. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.008.","journal-title":"Cancer Cell"},{"key":"8677_CR74","first-page":"593","volume":"105","author":"T Otamiri","year":"1989","unstructured":"Otamiri T. Oxygen radicals, lipid peroxidation, and neutrophil infiltration after small-intestinal ischemia and reperfusion. Surgery. 1989;105:593\u20137.","journal-title":"Surgery"},{"key":"8677_CR75","doi-asserted-by":"publisher","first-page":"944494","DOI":"10.3389\/fonc.2022.944494","volume":"12","author":"J Deng","year":"2022","unstructured":"Deng J, Jiang R, Meng E, Wu H. CXCL5: a coachman to drive cancer progression. Front Oncol. 2022;12:944494 https:\/\/doi.org\/10.3389\/fonc.2022.944494.","journal-title":"Front Oncol"},{"key":"8677_CR76","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O. Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer. 2017;17:577\u201393. https:\/\/doi.org\/10.1038\/nrc.2017.77.","journal-title":"Nat Rev Cancer"},{"key":"8677_CR77","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1541-7786.mcr-14-0155","volume":"13","author":"M Puig","year":"2015","unstructured":"Puig M, Lugo R, Gabasa M, Gim\u00e9nez A, Velasquez A, Galgoczy R, et al. Matrix stiffening and beta(1) integrin drive subtype-specific fibroblast accumulation in lung cancer. Mol Cancer Res. 2015;13:161\u201373. https:\/\/doi.org\/10.1158\/1541-7786.mcr-14-0155.","journal-title":"Mol Cancer Res"},{"key":"8677_CR78","doi-asserted-by":"publisher","first-page":"15935","DOI":"10.1074\/jbc.M112.341156","volume":"287","author":"J Batra","year":"2012","unstructured":"Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure. J Biol Chem. 2012;287:15935\u201346. https:\/\/doi.org\/10.1074\/jbc.M112.341156.","journal-title":"J Biol Chem"},{"key":"8677_CR79","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/bjc.2017.270","volume":"117","author":"M Gabasa","year":"2017","unstructured":"Gabasa M, Ikemori R, Hilberg F, Reguart N, Alcaraz J. Nintedanib selectively inhibits the activation and tumor-promoting effects of fibroblasts from lung adenocarcinoma patients. Br J Cancer. 2017;117:1128\u201338.","journal-title":"Br J Cancer"},{"key":"8677_CR80","doi-asserted-by":"publisher","first-page":"154954","DOI":"10.1016\/j.metabol.2021.154954","volume":"127","author":"EK Valanti","year":"2022","unstructured":"Valanti EK, Dalakoura-Karagkouni K, Fotakis P, Vafiadaki E, Mantzoros CS, Chroni A, et al. Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1\/2, AKT and p38 MAPK. Metabolism. 2022;127:154954 https:\/\/doi.org\/10.1016\/j.metabol.2021.154954.","journal-title":"Metabolism"},{"key":"8677_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-019-0504-3","author":"D Park","year":"2019","unstructured":"Park D, Wershof E, Boeing S, Labernadie A, Jenkins RP, George S, et al. Extracellular matrix anisotropy is determined by TFAP2C-dependent regulation of cell collisions. Nat Mater. 2019. https:\/\/doi.org\/10.1038\/s41563-019-0504-3.","journal-title":"Nat Mater"},{"key":"8677_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:323. https:\/\/doi.org\/10.1186\/1471-2105-12-323.","journal-title":"BMC Bioinforma"},{"key":"8677_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"8677_CR84","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","volume":"29","author":"W Luo","year":"2013","unstructured":"Luo W, Brouwer C. Pathview: an R\/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29:1830\u20131. https:\/\/doi.org\/10.1093\/bioinformatics\/btt285.","journal-title":"Bioinformatics"},{"key":"8677_CR85","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36:2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"key":"8677_CR86","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nbt1210-1248","volume":"28","author":"M Uhlen","year":"2010","unstructured":"Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, et al. Towards a knowledge-based human protein atlas. Nat Biotechnol. 2010;28:1248\u201350. https:\/\/doi.org\/10.1038\/nbt1210-1248.","journal-title":"Nat Biotechnol"},{"key":"8677_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01127-6","volume":"14","author":"AL Parker","year":"2022","unstructured":"Parker AL, Bowman E, Zingone A, Ryan BM, Cooper WA, Kohonen-Corish M, et al. Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma. Genome Med. 2022;14:126. https:\/\/doi.org\/10.1186\/s13073-022-01127-6.","journal-title":"Genome Med"},{"key":"8677_CR88","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08677-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08677-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:30:10Z","timestamp":1778225410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08677-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8677"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08677-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"29 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by our institutional Ethics Committees: Fundaci\u00f3 Parc Taul\u00ed (CIBERES cohort), Universitat de Barcelona and Hospital Cl\u00ednic de Barcelona (fibroblast collection). Informed consent was obtained from all patients. In vivo studies were approved by the Animal Care and Ethics Committee of the Universitat de Barcelona. All methods were performed in accordance with the relevant guidelines and regulations, in agreement with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"431"}}